Beranda › Kanker Prostat › Indiana
Uji klinis Kanker Prostat di Indiana
24 studi untuk Kanker Prostat mencari peserta di lokasi di Indiana.
Kota di Indiana
Teks studi resmi (Bahasa Inggris)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- IU Simon Cancer Center, Indianapolis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Reid Health, Richmond
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Urology of Indiana - Carmel ( Site 0055), Carmel
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Indiana University, Indianapolis
Menerima pesertaFase 2/3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06780670A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Greenwood
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 18 Sep 2026 · NCT06952803Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Indiana University School of Medicine, Indianapolis
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Goshen Center for Cancer Care, Goshen
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- First Urology PSC, Jeffersonville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07723248Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Indiana University, Indianapolis
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 21 Agu 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Community Health Network, Indianapolis
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 20 Agu 2026 · NCT06785636Sonablate HIFU International Registry for PC & BPH Patients
- Indiana University Medical Center, Indianapolis
Menerima pesertaStudi observasional
Usia 18 ke atas · Pria · Diperbarui 13 Agu 2026 · NCT07757490PSMA PET Combined With MRI for the Detection of PCa
- Indiana University, Indianapolis
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 ke atas · Pria · Diperbarui 23 Jul 2026 · NCT07052214Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- First Urology, Jeffersonville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Parkview Research Center, Fort Wayne
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Parkview Research Center, Fort Wayne
Menerima pesertaFase 4
Usia 18 hingga 100 · Pria · Diperbarui 4 Jun 2026 · NCT05803941Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Menerima pesertaFase 2/3
Usia 18 ke atas · Pria · Diperbarui 8 Apr 2026 · NCT04787744ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
- IU Health Joe and Shelly Schwarz Cancer Center, Carmel
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Methodist Hospital, Indianapolis
Menerima peserta
Usia 40 ke atas · Pria · Diperbarui 25 Feb 2026 · NCT05879913A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- First Urology, Jeffersonville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 4 Feb 2026 · NCT04729114Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Reid Health, Richmond
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 22 Jan 2026 · NCT06470243cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Floyd, New Albany
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 18 ke atas · Pria · Diperbarui 31 Des 2025 · NCT06084338Evaluating Tolerability of ePUHRT With Brachytherapy Boost
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 26 Sep 2025 · NCT06817668Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Reid Health, Richmond
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025PSMA-PET to Guide Prostatectomy
- Goodman Hall, Indiana Institute for Biomedical Imaging Sciences, Indiana University School of Medicine, Indianapolis
Menerima pesertaFase 2/3
Usia 40 hingga 80 · Pria · Diperbarui 31 Jan 2025 · NCT05381103Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.